126 related articles for article (PubMed ID: 1723740)
1. Immunotherapy with antibodies to core lipopolysaccharide: a critical appraisal.
Baumgartner JD
Infect Dis Clin North Am; 1991 Dec; 5(4):915-27. PubMed ID: 1723740
[TBL] [Abstract][Full Text] [Related]
2. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
Calandra T; Baumgartner JD; Glauser MP
Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
[TBL] [Abstract][Full Text] [Related]
3. Adoptive immunotherapy of gram-negative sepsis: use of monoclonal antibodies to lipopolysaccharide.
Fink MP
Crit Care Med; 1993 Feb; 21(2 Suppl):S32-9. PubMed ID: 8428494
[TBL] [Abstract][Full Text] [Related]
4. Pilot study of anti-lipopolysaccharide human monoclonal antibody MAB-T88 in patients with gram-negative sepsis.
Daifuku R; Panacek EA; Haenftling K; Swenson WK; Prescott AW; Johnson JL
Hum Antibodies Hybridomas; 1993 Jan; 4(1):36-9. PubMed ID: 8431557
[TBL] [Abstract][Full Text] [Related]
5. The role of monoclonal antibodies in the management of gram-negative sepsis. Experience with the E5 antibody.
Gorelick KJ; Chmel H
Infect Dis Clin North Am; 1991 Dec; 5(4):899-913. PubMed ID: 1783775
[TBL] [Abstract][Full Text] [Related]
6. Production, characterization and biological effects of monoclonal antibodies to different parts of the gram-negative lipopolysaccharide core region.
Appelmelk BJ; Verweij-van Vught M; Brade H; Maaskant J; Schouten W; Thijs B; MacLaren D
Prog Clin Biol Res; 1988; 272():373-82. PubMed ID: 2455918
[No Abstract] [Full Text] [Related]
7. Life-saving immunotherapy with cross-reactive monoclonal antibodies against endotoxin: a critical evaluation of experimental and clinical studies.
Cornelissen JJ; Schellekens JF; Kraaijeveld CA; Verhoef J
Neth J Med; 1991 Oct; 39(3-4):170-6. PubMed ID: 1791879
[TBL] [Abstract][Full Text] [Related]
8. Immunization with antibodies that mimic LPS protects against gram negative bacterial sepsis.
Klaerner HG; Dahlberg PS; Acton RD; Battafarano RJ; Uknis ME; Johnston JW; Dunn DL
J Surg Res; 1997 May; 69(2):249-54. PubMed ID: 9224390
[TBL] [Abstract][Full Text] [Related]
9. Immunoprophylaxis and immunotherapy of gram-negative sepsis and shock with antibodies to core glycolipids and lipid A of bacterial lipopolysaccharides.
Mitov IG; Terziiski DG
Infection; 1991; 19(6):383-90. PubMed ID: 1816107
[No Abstract] [Full Text] [Related]
10. Immunotherapy of endotoxemia and septicemia.
Baumgartner JD; Glauser MP
Immunobiology; 1993 Apr; 187(3-5):464-77. PubMed ID: 8330909
[TBL] [Abstract][Full Text] [Related]
11. Production and characterisation of mouse monoclonal antibodies reacting with the lipopolysaccharide core region of gram-negative bacilli.
Appelmelk BJ; Verweij-van Vught AM; Maaskant JJ; Schouten WF; De Jonge AJ; Thijs LG; Maclaren DM
J Med Microbiol; 1988 Jun; 26(2):107-14. PubMed ID: 2455054
[TBL] [Abstract][Full Text] [Related]
12. Possibilities of immunoprophylaxis and immunotherapy in gut-derived infectious-toxic shock (GITS).
Imbach P; Hässig A; Cottier H
Curr Stud Hematol Blood Transfus; 1992; (59):301-23. PubMed ID: 1572217
[No Abstract] [Full Text] [Related]
13. Novel immunotherapeutic approaches to the treatment of infections caused by Gram-negative bacteria.
Palliyil S; Broadbent ID
Curr Opin Pharmacol; 2009 Oct; 9(5):566-70. PubMed ID: 19726227
[TBL] [Abstract][Full Text] [Related]
14. [Generation and characterization of avian vitelline antibodies against lipopolysaccharide and lipid A. 1. Induction and preparation of specific egg yolk antibodies (IgY) against endotoxins].
Sasse M; Krüger M; Schade R; Hlinak A
Berl Munch Tierarztl Wochenschr; 1998 Apr; 111(4):121-6. PubMed ID: 9581345
[TBL] [Abstract][Full Text] [Related]
15. Immunoprotective murine monoclonal antibodies specific for the outer-core polysaccharide and for the O-antigen of Escherichia coli 0111:B4 lipopolysaccharide (LPS).
Coughlin RT; Bogard WC
J Immunol; 1987 Jul; 139(2):557-61. PubMed ID: 3298431
[TBL] [Abstract][Full Text] [Related]
16. Anti-lipopolysaccharide antibodies in gram-negative bacteremia.
Baumgartner JD
Behring Inst Mitt; 1991 Feb; (88):216-21. PubMed ID: 2049041
[TBL] [Abstract][Full Text] [Related]
17. [Generation and characterization of avian vitelline antibodies against lipopolysaccharide and lipid A. 2. Investigations of specificity of egg yolk antibodies (IgY) against endotoxin].
Sasse M; Hlinak A
Berl Munch Tierarztl Wochenschr; 1998 Apr; 111(4):127-33. PubMed ID: 9581346
[TBL] [Abstract][Full Text] [Related]
18. Use of hybridoma immunoglobulin switch variants in the analysis of the protective properties of anti-lipopolysaccharide antibodies in Escherichia coli K1 infection.
Pelkonen S; Pluschke G
Immunology; 1989 Oct; 68(2):260-4. PubMed ID: 2680911
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies that recognize epitopes in the core and lipid A region of lipopolysaccharides.
Pollack M; Chia JK; Koles NL; Miller M; Guelde G
Prog Clin Biol Res; 1988; 272():327-38. PubMed ID: 2455917
[No Abstract] [Full Text] [Related]
20. Immunotherapy of gram-negative septicemia.
van Deventer SJ
Prog Clin Biol Res; 1991; 367():135-9. PubMed ID: 1924423
[No Abstract] [Full Text] [Related]
[Next] [New Search]
